Bempedoic acid: all 43 studies that test it

Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.

• Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary SyndromeRecruitingNCT07824323Phase 4
• A Clinical Study to Evaluate the Efficacy and Safety of Bempedoic AcidNot yet recruitingNCT07623915Phase 3
• Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary SyndromeNot yet recruitingNCT07508254Phase 4
• A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular EventsNot yet recruitingNCT07474649Phase 3
• Bempedoic Acid Therapy for Polycystic Kidney DiseaseRecruitingNCT07282821Phase 2
• Bempedoic Acid Versus Statins in Primary-Prevention Patients With Suboptimal Statin Adherence: Effects on LDL-C Reduction and TolerabilityNot yet recruitingNCT07239414Phase 3
• A Clinical Study to Evaluate the Efficacy, Tolerability, and Safety of Bempedoic AcidRecruitingNCT06780410Phase 3
• Effect of Bempedoic Acid on Liver Fat in Individuals With Nonalcoholic Fatty Liver Disease and Type 2 DiabetesRecruitingNCT06035874Not applicable
• Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target)Not yet recruitingNCT05587621Not applicable
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)RecruitingNCT05488431Phase 2
• Milk-Only Lactation Study to Evaluate the Concentration of Bempedoic Acid and Bempedoic Acid/Ezetimibe Fixed Combination Drug Product (FCDP) in the Breast Milk of Healthy Lactating WomenCompletedNCT06021951Phase 4Results posted
• A Clinical Study in Children With Heterozygous Familial Hypercholesterolemia (HeFH) Aged 6 to 17 Treated Once Daily With Bempedoic Acid Oral Dosing (CLEAR Path 1)CompletedNCT05694260Phase 2Results posted
• A Long-term Trial of ETC-1002 in Patients With Hyper-LDL CholesterolemiaCompletedNCT05687071Phase 3Results posted
• A Confirmatory Trial of ETC-1002 in Patients With Hyper-LDL CholesterolemiaCompletedNCT05683340Phase 3Results posted
• A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With HypercholesterolemiaCompletedNCT04784442Phase 2Results posted
• A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin TherapyCompletedNCT03337308Phase 3Results posted
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor TherapyCompletedNCT03193047Phase 2Results posted
• Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)CompletedNCT03067441Phase 3Results posted
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-CCompletedNCT03051100Phase 2Results posted
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)CompletedNCT03001076Phase 3Results posted
• Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or PlaceboCompletedNCT02993406Phase 3Results posted
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular RiskCompletedNCT02991118Phase 3Results posted
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin IntolerantCompletedNCT02988115Phase 3Results posted
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)CompletedNCT02666664Phase 3Results posted
• Evaluation of ETC-1002 in Participants With Hypercholesterolemia and HypertensionCompletedNCT02178098Phase 2Results posted
• A Study of the Efficacy and Safety of ETC-1002 in Participants With Statin IntoleranceCompletedNCT01751984Phase 2Results posted
• A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated TriglyceridesCompletedNCT01262638Phase 2Results posted
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid / Ezetimibe, and AtorvastatinCompletedNCT07268625Phase 1
• Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL CholesterolCompletedNCT07255820Phase 4
• A Study Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and AtorvastatinCompletedNCT07235189Phase 1
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Tablets of Bempedoic Acid / Ezetimibe and RosuvastatinCompletedNCT07201545Phase 1
• Evaluating Bioequivalence of a Fixed Dose Combination Versus Individual Tablets of Bempedoic Acid, Ezetimibe, and RosuvastatinCompletedNCT07182383Phase 1
• Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated TabletsCompletedNCT07170852Phase 1
• A Study to Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in TaiwanCompletedNCT06925100Phase 4
• Single Dose Oral Bioequivalence Study of Bempedoic Acid 180 mg Film Coated Tablet and Nilemdo® (Bempedoic Acid) 180 mg Film-coated Tablets in Healthy Adult Human Subjects Under Fasting Conditions.CompletedNCT06923956Phase 1
• A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.CompletedNCT06742853Phase 1
• Cholesterol Lowering Via Bempedoic Acid/Ezetimibe, an ACL-Inhibiting Regimen in Acute Coronary Syndrome StudyStatus unknownNCT05263778Phase 4
• A Study Of Pharmacokinetics, Pharmacodynamics And Safety Of Adding ETC-1002 To Atorvastatin 80 mgCompletedNCT02659397Phase 2
• Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin TherapyCompletedNCT02072161Phase 2
• Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsCompletedNCT01941836Phase 2
• A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With HypercholesterolemiaCompletedNCT01779453Phase 2
• A Single Center Study to Evaluate the Efficacy and Safety of ETC 1002 in Subjects With Type 2 DiabetesCompletedNCT01607294Phase 2
• A Multiple Ascending Dose Study of ETC-1002 in Healthy SubjectsCompletedNCT01485146Phase 1

← Bempedoic acid overview